GEORGE YANCOPOULOS

Insider Reports History

Location
Tarrytown, NY
Signature
By: Richard Gluckselig as attorney-in-fact For: George D. Yancopoulos
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by GEORGE YANCOPOULOS:

Company Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Common Stock 310,460 $239,703,061 $772.09 31 Dec 2025 Direct
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Common Stock 200,000 $138,516,000 $692.58 31 Dec 2025 By 2025 GRAT
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Common Stock 200,000 $138,516,000 $692.58 31 Dec 2025 By 2025 GRAT II
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Common Stock 180,000 $124,664,400 $692.58 31 Dec 2025 By Trust for Chldn.
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Common Stock 101,988 $70,634,849 $692.58 31 Dec 2025 by 2024 GRAT II
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Common Stock 71,487 $49,510,466 $692.58 31 Dec 2025 By 2024 GRAT
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Common Stock 56,048 $38,817,723 $692.58 31 Dec 2025 by Children
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Common Stock 5,962 $4,129,161 $692.58 31 Dec 2025 By 401(k) Plan
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director 2020 Performance Stock Units 595,077 31 Dec 2025 Direct
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director Non-Qualified Stock Option (right to buy) 0 09 Dec 2025 Direct

Insider Reports Filed by GEORGE YANCOPOULOS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
REGN REGENERON PHARMACEUTICALS, INC. 31 Dec 2025 3 -$22,058,611 4 Bd. Co-Chair, President & CSO, Director 05 Jan 2026, 17:54
REGN REGENERON PHARMACEUTICALS, INC. 09 Dec 2025 3 -$10,930,239 4 Bd. Co-Chair, President & CSO, Director 11 Dec 2025, 16:27
REGN REGENERON PHARMACEUTICALS, INC. 10 Jun 2024 2 $0 4 Bd. Co-Chair, President & CSO, Director 12 Jun 2024, 16:10
REGN REGENERON PHARMACEUTICALS, INC. 16 May 2024 12 -$48,636,545 4 Bd. Co-Chair, President & CSO, Director 17 May 2024, 16:06
REGN REGENERON PHARMACEUTICALS, INC. 15 May 2024 25 -$48,793,727 4 Bd. Co-Chair, President & CSO, Director 17 May 2024, 16:04
REGN REGENERON PHARMACEUTICALS, INC. 29 Apr 2024 2 $0 4 Bd. Co-Chair, President & CSO, Director 01 May 2024, 16:03
REGN REGENERON PHARMACEUTICALS, INC. 15 Feb 2024 3 -$48,863,868 4 Bd. Co-Chair, President & CSO, Director 20 Feb 2024, 16:03
REGN REGENERON PHARMACEUTICALS, INC. 02 Jan 2024 1 -$15,163,200 4 Bd. Co-Chair, President & CSO, Director 01 May 2024, 16:00
REGN REGENERON PHARMACEUTICALS, INC. 02 Jan 2024 1 -$15,163,200 4 Bd. Co-Chair, President & CSO, Director 04 Jan 2024, 16:20
REGN REGENERON PHARMACEUTICALS, INC. 11 Dec 2023 3 -$10,838,960 4 Bd. Co-Chair, President & CSO, Director 13 Dec 2023, 16:05
REGN REGENERON PHARMACEUTICALS, INC. 23 Mar 2023 8 -$2,940,374 4 President and Chief Scientific, Director 27 Mar 2023, 16:41
REGN REGENERON PHARMACEUTICALS, INC. 06 Feb 2023 1 -$10,552,255 4 President and Chief Scientific, Director 08 Feb 2023, 15:15
REGN REGENERON PHARMACEUTICALS, INC. 22 Dec 2021 6 -$91,395,761 4 President and Chief Scientific, Director 23 Dec 2021, 15:29
REGN REGENERON PHARMACEUTICALS, INC. 13 Aug 2021 3 -$31,264,263 4 President and Chief Scientific, Director 17 Aug 2021, 16:13
REGN REGENERON PHARMACEUTICALS, INC. 05 Aug 2021 3 -$30,003,000 4 President and Chief Scientific, Director 06 Aug 2021, 16:03
REGN REGENERON PHARMACEUTICALS, INC. 21 Jun 2021 17 -$43,112,141 4 President and Chief Scientific, Director 23 Jun 2021, 16:02